BRAF and thyroid cancer: Associations of osteopontin expression and mutated BRAF may represent another prospective source of evidence according to which osteopontin could be inducing EMT in thyroid cancer, whereby BRAF mutation, especially BRAF V600E, is closely related to EMT activation [90,91].